The Yale Innovation Summit is a day-long event tailored to Yale innovators to encourage the sharing of new discoveries and technologies with market potential with the broader investment community.

Held at Yale School of Management, and presented by the Office of Cooperative Research and the Yale Entrepreneurial Institute, last year’s event featured more than 350 attendees including faculty members, local industry executives, students and post-docs.  Additionally, over 50 venture capital investors were represented from over 25 firms that in aggregate had over $40 billion under management. This was the most significant gathering of venture investors ever on Yale’s campus.


5AM Ventures, Atlas Venture, F-Prime Capital Partners, TPG Capital, Nyca Partners, OrbiMed, Polaris Partners, New Enterprise Associates, Oak HC/FT, New Leaf Venture Partners, Samsung Ventures, Polaris Partners, Sanofi-Genzyme BioVentures, Johnson & Johnson, Novartis Venture Funds, Evolution Life Science Partners


  • Kevin Bitterman, Partner, Polaris Partners
  • Christine Brennan, Principal, Novartis Venture Funds
  • Gerald Chan, Cofounder, Morningside Group
  • Christopher J. Denn, Partner, Goodwin
  • Jason Hafler, Senior Director of Investments, Sanofi-Genzyme BioVentures
  • Roy Herbst, Associate Director for Translational Research, Yale Cancer Center
  • Paul Hermes, Entrepreneur-in-Residence, Medtronic
  • Jim Hornthal, Chairman, M34 Capital, Zignal Labs
  • Hyuk Jeen-Suh, Head of Samsung Ventures East Coast
  • Ken Kaufmann, VP Marketing, Hamamatsu
  • Patricia Kemp, General Partner, Oak HC/FT
  • Chau Khuong, Private Equity Partner, OrbiMed
  • Stephen Knight, President and Managing Partner, F-Prime Capital Partners
  • Kathleen McGroddy-Goetz, VP, Partnerships & Solutions, IBM Watson Health
  • James Murphy, CEO, EquityNet
  • Sara Nayeem, Partner, New Enterprise Associates
  • Lili Portilla, Director of Office Strategic Alliances, NCATS
  • Liam Ratcliffe, Managing Director, New Leaf Venture Partners
  • Jeffrey Reitman, Principal, Nyca Partners
  • Jason Rhodes, Partner, Atlas Venture
  • Helge Seetzen, General Partner, Tandem Launch
  • Stephen Squinto, Venture Partner, OrbiMed
  • Mary Tanner, Senior Managing Director, Evolution Life Science Partners
  • Lou Tartaglia, Executive-in-Residence, 5AM Ventures
  • James Tobin, Vice President, Cardiovascular and Metabolism Scientific Innovation, Johnson & Johnson
  • Jarrod Yuster, CEO, Pico Quantitative Trading